Company: PMVP
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030414
Chunk: 3

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 15
Chunk 3
---
 29, 2024

    19.1*
     
    Insider Trading Policy.

    21.1
     
    List of Subsidiaries.
     
    10-K
     
    001-39539
     
    21.1
     
    March 1, 2022

    23.1*
     
    Consent of Independent Registered Public Accounting Firm.

    24.1*
     
    Power of Attorney (contained in the signature page to this Annual Report on Form 10-K).

    31.1*
     
    Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    31.2*
     
    Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    32.1*#
     
    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

    32.2*#
     
    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

    97.1+
     
    Compensation Recovery Policy.
     
    10-K
     
    001-39539
     
    97.1
     
    February 29, 2024

 128

    101.INS
     
    Inline XBRL Instance Document-the Instance Document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document

    104
     
    Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

* Filed herewith.

+ Indicated management contract or compensatory plan.

# The certifications attached as Exhibits